The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Down Amid Covid-19 Resurgence In Europe

Mon, 26th Oct 2020 12:08

(Alliance News) - Stocks in London were recovering from steep morning losses at midday on Monday as investors weighed a rise in coronavirus cases on the European continent against progress on a vaccine.

Equity markets in the UK and Europe fell sharply in morning trade amid a surge of coronavirus cases across the US and in mainland Europe. The new wave already had forced governments in several countries including the UK, Germany and France to reimpose tough restrictions to prevent the disease from spreading.

Spain declared a national state of emergency on Sunday to tackle a second coronavirus wave as the World Health Organization reported a third straight day of record new infections across the world.

The WHO has warned that some countries are on a "dangerous track", with too many witnessing an exponential increase in cases, and called on countries to take further action to curb the spread of the disease.

In total, the UN agency's figures showed that 465,319 cases were declared on Saturday alone, half of them in Europe.

Further, Italy has ordered the closure of theatres, cinemas and gyms and said bars and restaurants must shut early.

The FTSE 100 index was down 5.25 points, or 0.1%, at 5,855.03. The FTSE 250 was down 31.35 points, or 0.2%, at 18,078.22. The AIM All-Share was up 3.07 points, or 0.3%, at 983.52.

The Cboe UK 100 was up 0.1% at 582.68, the Cboe 250 was flat at 15,333.56, and the Cboe Small Companies was up 0.6% at 9,720.09.

In Paris, the CAC 40 was down 0.7%, while the DAX 30 in Frankfurt was down 2.1%.

"While we are seeing nations attempt to stifle the spread of the virus through more localised and tentative restrictions, it seems highly likely that we will eventually see a swathe of nationwide lockdowns if the trajectory cannot be reversed. With travel stocks such as TUI and Carnival getting hit in early trade, it is clear that traders are preparing for a raft of more restrictive measures," said IG Group's Josh Mahony.

"Despite the rise in Covid cases, traders remain torn as they weigh up the potential impending benefits of a US stimulus package and potential vaccine. The latest update from Oxford highlighted how their early trials show a positive reaction to the vaccine for the elderly, with an immune response for those at most risk likely to prove a key cornerstone for any worthy vaccine candidate," Mahony added.

AstraZeneca was up 1.2% after the Anglo-Swedish drugmaker late Friday said clinical trials for its AZD1222 coronavirus vaccine, being developed alongside Oxford University, has been resumed around the world, as regulators in the US, UK, Brazil, South Africa and Japan confirmed that it is safe to do so.

The US Food & Drug Administration authorised the restart of the trials in the US, as they resumed in other countries in recent weeks, following the review of all safety data from trials in other regions.

The biggest riser in the FTSE 100, however, was Pearson. The education publisher was up 4.1%, after UBS upgraded the stock to Buy from Neutral, Pearson's US Higher Education business can hold the key to substantial growth in earnings going forward.

At the other end of the large caps, Royal Dutch Shell 'A' and 'B' shares were down 1.1% and 0.9%, respectively, tracking spot oil prices lower.

Brent oil was trading at USD40.98 a barrel on Monday at midday, down sharply from USD42.25 late Friday.

Warring factions in Libya signed a countrywide ceasefire on Friday brokered by the United Nations. The ceasefire is poised to lead to more Libyan oil supply to the market at a time when demand is weak.

In the FTSE 250, Anglo-German travel company Tui was the worst performer, down 5.8%, and cruise line operator Carnival was down 2.5% on fresh worries over Covid-19 travel restrictions.

Elsewhere, THG Group was up 13% after the online retailing platform raised its revenue guidance for 2020, following strong trading in the third quarter and continued momentum in the fourth quarter to date.

THG said that, for the three months to the end of September, total revenue grew by 39% year-on-year to GBP378.1 million. For the first nine months of 2020, revenue increased by 37% to GBP1.05 billion.

THG listed in London last month with a market capitalisation of GBP5.40 billion and at the time guided for annual revenue of GBP1.43 billion.

However, as a result of the stronger quarterly performance, the group now expects revenue to be between GBP1.48 billion to GBP1.52 billion, reflecting a 30% to 33% increase from GBP1.14 billion the year before.

The pound was quoted at USD1.3057 Monday at midday, flat from USD1.3050 at the London equities close Friday.

The euro was priced at USD1.1828, lower from USD1.1840. Against the yen, the dollar was trading at JPY104.87, marginally up from JPY104.80.

Elsewhere in commodities, gold was quoted at USD1,897.25 an ounce, down from USD1,900.50 late Friday.

US stock market futures were pointed lower as coronavirus infections in the US surged, while negotiations for a fiscal stimulus package before next week's election continue.

The Dow Jones Industrial Average was called down 0.9%, the S&P 500 down 0.8% and the Nasdaq Composite down 0.6%.

In the US, a record of nearly 80,000 new Covid-19 infections over the course of a day were reported on Friday, according to figures from Johns Hopkins University.

The virus has now claimed the lives of 1.1 million people and infected more than 42 million globally.

Meanwhile, China on Monday announced sanctions on US arms dealers, days after Washington approved the sale of weapons worth USD1 billion to Taiwan.

The sanctioned companies include Lockheed Martin, Boeing and Raytheon Technologies, according to Chinese Foreign Ministry spokesman Zhao Lijian. Zhao didn't detail the sanctions.

In the New York pre-market Monday, Boeing was down 1.9% and Raytheon down 1.5%. Lockheed Martin wasn't quoted in the pre-market session.

The move comes after the US on Wednesday approved the sale of three weapons systems worth just over USD1 billion to Taiwan, which Beijing sees as a breakaway province.

Ahead, US earnings season kicks into high gear this week with Microsoft, Pfizer, Merck, 3M and Caterpillar reporting on Tuesday, along with Visa, PayPal, Boeing, General Electric, eBay, Ford on Wednesday.

Tech companies Apple, Amazon, Alphabet and Facebook report on Thursday, while oil majors Chevron and ExxonMobil deliver earnings on Friday.

"The FANGs have been the primary drivers of the rebound in stocks, and their profit picture as well as forward guidance will be crucial to any further rally in the indices. If the high tech darlings fail to meet the expectations of investors the market could set up for a vicious downward slide as investors will face risk from Covid lockdowns, lack of fiscal stimulus, and peak growth in work from home stocks," analysts at BK Asset Management said.

The economic events calendar on Monday has US new home sales at 1500 GMT.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.